Effect of thyroid-stimulating hormone suppression on quality of life in thyroid lobectomy patients: interim analysis of a multicenter, randomized controlled trial in low- to intermediate-risk thyroid cancer patients (MASTER study)

• DOI: 10.4174/astr.2024.106.1.19
• Publication Date: 2024-01-07T23:40:30Z
• Authors: Ja Kyung Lee; Eu Jeong Ku; Su-jin Kim; Woochul Kim; Jae Won Cho; Kyong Yeun Jung; Hyeong Won Yu; Yea Eun Kang; Mijin Kim; Hee Kyung Kim; Junsun Ryu; June Young Choi
• Keywords: Thyroid-stimulating hormone; Interim analysis

Current clinical practices favor less or no thyroid-stimulating hormone (TSH) suppression for low- to intermediate-risk thyroid cancer patients who receive lobectomy. The association of TSH on health-related quality life (HR-QoL) in after lobectomy is not well studied. This study aimed evaluate the effect patient HR-QoL